Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR122 host gene (MIR122HG) is a long non-coding RNA that serves as the primary transcript and host gene for the liver-specific microRNA miR-122-5p[1][5]. MIR122HG undergoes processing to produce miR-122, which is highly abundant in hepatocytes and plays major roles in metabolic homeostasis, antiviral responses, and tumor suppression. Overexpression or knockdown of MIR122HG regulates miR-122 expression and thereby influences liver cell proliferation, immune signaling, and the host response to viral infections such as hepatitis C[1]. MIR122HG itself functions mainly by controlling the availability of miR-122-5p, and is not known to have independent protein-coding or receptor/enzymatic activities. It is not currently considered a direct therapeutic target, although its product (miR-122) is being investigated for clinical applications in liver diseases and viral hepatitis therapy[1][2][5]. The misregulation of MIR122HG or miR-122 is implicated in hepatocellular carcinoma and other liver pathologies[2][3][4].
Not directly targeted by drugs; acts by providing the primary transcript for miR-122-5p, which regulates gene expression post-transcriptionally
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR122 host gene (MIR122HG).